Here, we have shown a significant negative correlation between FoxO1 expression and grading, whereby well-differentiated NETs (G1-G2) cases have a persistent positive FoxO1 nuclear/cytoplasmatic expression that decreases with the tumor progression, confirming the more favorable outcomes in patients G1/G2 GEP-NETs. This evidence concerns the gene FOXO1 and neoplasm.